Sequegenics
Atlanta
About Sequegenics
Sequegenics is a biotechnology company developing next-generation multi-omics solutions that combine long-read genome and transcriptome sequencing with proteomics, and AI-powered analytics to uncover hidden layers of biology. Our proprietary technology enables high-throughput, high-resolution data generation that captures complex genetic signatures often missed by conventional approaches. By integrating these rich datasets into a unified analysis platform, we deliver unique insights into biological systems ’ accelerating target discovery, improving disease modeling, and powering the development of high-value therapeutic assets. With applications across drug discovery, rare disease research, and precision medicine, Sequegenics is building a scalable engine to transform biological complexity into actionable intelligence.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $896.0K
- Funding stage: Seed
- Last round: Pre-Seed (Aug 2023)
- Website: sequegenics.com
Industries & Categories
Biopharma, Biotechnology, Health Diagnostics, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/sequegenics-53027 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.